{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T16:47:07Z","timestamp":1648831627437},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.reuma.2009.04.010","type":"journal-article","created":{"date-parts":[[2009,10,19]],"date-time":"2009-10-19T08:03:17Z","timestamp":1255939397000},"page":"56-57","source":"Crossref","is-referenced-by-count":0,"title":["Respuesta a rituximab en un paciente con granulomatosis de Wegener refractaria a terapia convencional"],"prefix":"10.1016","volume":"6","author":[{"given":"Inmaculada","family":"Mac\u00edas Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2009.04.010_bib1","first-page":"93","article-title":"Update on medium and small vessel vasculitides","volume":"53","author":"Seo","year":"2005","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.reuma.2009.04.010_bib2","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.04.010_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/00003495-200868060-00003","article-title":"Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"68","author":"Lee","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.reuma.2009.04.010_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200809020-00001","article-title":"Clinical approach to cutaneous vasculitis","volume":"9","author":"Chen","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.reuma.2009.04.010_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reuma.2009.04.010_bib6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","article-title":"Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab","volume":"45","author":"Stasi","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.reuma.2009.04.010_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/RHU.0b013e31816b4487","article-title":"Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease","volume":"14","author":"S\u00e1nchez Cano","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.reuma.2009.04.010_bib8","first-page":"S1","article-title":"What place for the new biologics in the treatment of necrotising vasculitides","volume":"24","author":"Wayne","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2009.04.010_bib9","doi-asserted-by":"crossref","unstructured":"Aries PM, Hellmich B, Voswinkel J, Both M, N\u00f6lle B, Holl-Ulrich K, et al. Lack of efficacy of rituximab in Wegener\u2019s granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis 2006; 65: 853-8. Epub 2005 Nov 3.","DOI":"10.1136\/ard.2005.044420"},{"key":"10.1016\/j.reuma.2009.04.010_bib10","first-page":"23","article-title":"Adjunction of rituximab to steroids and immunosuppressants for refractory\/relapsing Wegener's granulomatosis: a study on 8 patients","volume":"25","author":"Brihaye","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2009.04.010_bib11","first-page":"972A","article-title":"Rituximab: a novel remission induction agent in ANCA associated vasculitis. The design of an international, randomised trial (RITUXVAS)","volume":"18","author":"Jones","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X09002022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X09002022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:10:01Z","timestamp":1558595401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X09002022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1699258X09002022"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2009.04.010","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}